drug
as of 2026-07-01Siltuximab
MeSH C504234
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Brian Miller
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Siltuximab in Schizophrenia
NCT02796859Phase 1, Phase 2Unknown
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here